A lipid panel reports LDL ("bad" — the particle that builds artery plaque; optimal below 100 mg/dL, below 70 for high-risk), HDL ("good" — higher is generally favorable, 40–60+), and triglycerides (below 150; diet- and glucose-sensitive). LDL's causal role in heart disease is settled by genetics, trials and decades of data — lifetime exposure is what arteries integrate. Food effect sizes: soluble fiber, plant sterols and swapping saturated for unsaturated fats lower LDL 5–10% each; weight and sugar reduction move triglycerides most. Statins cut LDL 30–50% and events by about a quarter per 39 mg/dL drop, with side-effect folklore far exceeding trial reality. Very high LDL (190+) or family early-heart-attack history warrants a familial-hypercholesterolemia check.
Reading the panel
Cholesterol itself is neutral cargo — membrane material and hormone feedstock — and the panel really measures the particles hauling it:
| Measure | Target zone (mg/dL) | Meaning |
|---|---|---|
| LDL | <100 optimal; <70 if high-risk; 190+ = genetics question | The plaque-delivering particle; the number treatment targets |
| HDL | 40+ (men), 50+ (women) | Cholesterol return-transport marker; predictive, not directly treatable |
| Triglycerides | <150 fasting | Metabolic weather-vane (FAQ); pancreatitis risk when very high |
| Total | <200 desirable | Blunt sum; least useful alone |
| Non-HDL (total − HDL) | <130 | Captures all plaque-capable particles; no fasting needed |
(Outside the US, divide mg/dL by ~38.7 for mmol/L: LDL 100 ≈ 2.6.) ApoB and Lp(a) are the panel's power-user additions — particle count and an inherited risk factor worth measuring once, respectively — increasingly ordered when risk decisions are close.
The settled part
That LDL causes atherosclerosis — rather than merely accompanying it — rests on convergent evidence few claims in medicine match: people born with low-LDL gene variants get proportionally less heart disease across lifetimes; people born with familial hypercholesterolemia (FH — LDL from birth of 190+, roughly 1 in 250, most undiagnosed) get it decades early; and every LDL-lowering mechanism tested at scale — statins, ezetimibe, PCSK9 inhibitors — reduces events in proportion to LDL reduction (~22% fewer major events per 39 mg/dL, compounding with duration). Arteries integrate LDL × time, which is why numbers matter at 35, not just 65, and why the FH question in the quick answer earns its urgency: early treatment normalizes an otherwise foreshortened risk curve.
What moves what
LDL, by food (each ~5–10%): swap saturated fats toward olive oil, nuts, seeds and fish; soluble fiber 5–10 g/day (oats, barley, beans, psyllium); plant sterols/stanols 2 g/day (fortified spreads; the mechanism behind beta-sitosterol); soy protein and nuts add smaller increments. Stacked faithfully (the "portfolio diet"), food reaches 20–30% — a low statin dose's territory, at the cost of consistency. Trans fats, where they linger, remain the one unambiguous villain.
Triglycerides: weight, added sugar and alcohol reduction, movement, and glucose control — the insulin-resistance playbook wearing a lipid label. Omega-3 at prescription doses treats very high levels; supplement-dose fish oil moves outcomes little.
Drugs: statins first — 30–50% LDL reduction, pennies, and the folklore-versus-trials reality in the FAQ; ezetimibe adds ~20%; PCSK9 inhibitors and inclisiran another 50–60% for high-risk or FH; bempedoic acid for the statin-intolerant. Red yeast rice, the aisle's statin-in-disguise, delivers unstandardized doses of the same molecule without monitoring — the honest description is "unregulated lovastatin," which settles it.
HDL: exercise, not smoking, weight — and acceptance that it's a marker (FAQ).
Testing and treating, practically
A first panel by the mid-30s (earlier with family history), then every 4–6 years while normal, annually once treating or diabetic — non-fasting is fine for most purposes. Treatment decisions weigh the panel inside overall risk (calculators fold in age, pressure, smoking, diabetes); LDL 190+, known vascular disease, or diabetes past 40 generally answer the statin question on their own. Repeat panels grade any change — food experiments included — at 8–12 weeks.
When to see a doctor
Book in for: any LDL 190+ or triglycerides 500+ (prompt), a first heart attack or stroke in a parent or sibling before 55/65 (FH screening for the family), tendon lumps or cholesterol deposits around eyes with high numbers, planning pregnancy on statins (they pause), or simply never having had a panel with any risk factor on board. Cholesterol gives no symptoms to wait for — the entire management of it is arithmetic done early, which is precisely what makes it one of medicine's most winnable games.
Frequently asked questions
Do eggs and dietary cholesterol raise blood cholesterol?
Far less than assumed for most people — the liver makes most circulating cholesterol and throttles down when diet supplies more. Guidelines quietly retired strict dietary-cholesterol limits; an egg or two daily is fine for most. The dietary lever that actually moves LDL is fat type: saturated (butter, fatty meat, coconut oil) up, unsaturated swaps down. "Hyper-responders" exist; a repeat panel after any big dietary change settles your own case.
Are statin side effects as common as everyone says?
In blinded trials, muscle symptoms occur at nearly identical rates on statin and placebo — the excess attributable to the drug is a few percent, and the n-of-1 studies (patients unknowingly alternating statin and placebo) show most "statin intolerance" reproduces on placebo. True serious harm (rhabdomyolysis) is rare; modest diabetes acceleration in the predisposed is real and outweighed by cardiac benefit. Genuine symptoms deserve dose/agent switches rather than abandonment — and deserve better than the internet's folklore.
My HDL is high — does that cancel a high LDL?
No. HDL predicts risk in populations, but raising it with drugs did nothing in trials, and very high HDL isn't protective — it's a marker more than a lever. Risk decisions ride on LDL (and its cousin non-HDL or ApoB), plus pressure, glucose, smoking, age and family history, increasingly summed by calculator rather than by single numbers offsetting each other.
What are triglycerides telling me?
Mostly about metabolism right now: they rise with excess calories, sugar and alcohol, inactivity, and insulin resistance — a high reading is often prediabetes waving. Below 150 is normal; 150–500 responds to weight, sugar, alcohol and movement; above 500 needs medication attention for pancreatitis risk. Fasting matters for this number more than the others.
References
- NHLBI. Blood Cholesterol (2024). https://www.nhlbi.nih.gov/health/blood-cholesterol
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Type 2 Diabetes (2023). https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/type-2-diabetes
This page contains no product recommendations or affiliate links. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.